O. Ganry

10.4k total citations
73 papers, 1.2k citations indexed

About

O. Ganry is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, O. Ganry has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in O. Ganry's work include Global Cancer Incidence and Screening (14 papers), Colorectal Cancer Screening and Detection (12 papers) and Cancer Risks and Factors (7 papers). O. Ganry is often cited by papers focused on Global Cancer Incidence and Screening (14 papers), Colorectal Cancer Screening and Detection (12 papers) and Cancer Risks and Factors (7 papers). O. Ganry collaborates with scholars based in France, Denmark and Spain. O. Ganry's co-authors include A. Dubreuil, Patrice Fardellone, C. Baudoin, Michel Velten, N Raverdy, Maxime Gignon, Brigitte Trétarre, Simona Bara, Anne‐Valérie Guizard and Anne‐Sophie Woronoff and has published in prestigious journals such as American Journal of Epidemiology, The American Journal of Cardiology and Annals of Oncology.

In The Last Decade

O. Ganry

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Ganry France 22 400 280 202 159 149 73 1.2k
Sean Robbins United States 16 145 0.4× 428 1.5× 104 0.5× 118 0.7× 192 1.3× 23 2.0k
Masahide Kondo Japan 27 145 0.4× 600 2.1× 158 0.8× 148 0.9× 223 1.5× 156 2.4k
Dilek Şahın Türkiye 28 319 0.8× 266 0.9× 210 1.0× 173 1.1× 490 3.3× 309 2.9k
Robert Lipnick United States 17 597 1.5× 478 1.7× 324 1.6× 191 1.2× 260 1.7× 25 2.5k
Louise Emilsson Sweden 22 419 1.0× 389 1.4× 179 0.9× 238 1.5× 454 3.0× 65 1.6k
Daniel Dedman United Kingdom 16 197 0.5× 339 1.2× 48 0.2× 441 2.8× 207 1.4× 36 1.5k
C E Chilvers United Kingdom 18 299 0.7× 112 0.4× 102 0.5× 262 1.6× 252 1.7× 26 1.2k
Lionel Pinto United States 17 226 0.6× 65 0.2× 58 0.3× 65 0.4× 118 0.8× 33 1.2k
Negar Rezaei Iran 21 337 0.8× 338 1.2× 44 0.2× 156 1.0× 214 1.4× 153 1.7k
Nader Esmailnasab Iran 16 202 0.5× 187 0.7× 36 0.2× 55 0.3× 66 0.4× 47 912

Countries citing papers authored by O. Ganry

Since Specialization
Citations

This map shows the geographic impact of O. Ganry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Ganry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Ganry more than expected).

Fields of papers citing papers by O. Ganry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Ganry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Ganry. The network helps show where O. Ganry may publish in the future.

Co-authorship network of co-authors of O. Ganry

This figure shows the co-authorship network connecting the top 25 collaborators of O. Ganry. A scholar is included among the top collaborators of O. Ganry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Ganry. O. Ganry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allaire, Manon, Julien Edeline, P. Merle, et al.. (2025). 1487P Extended follow-up at 42 months of atezolizumab–bevacizumab in advanced HCC: Insights from the CHIEF prospective study. Annals of Oncology. 36. S829–S829.
2.
Castelain, Sandrine, Étienne Brochot, Jean‐Luc Schmit, et al.. (2022). Hospital-wide SARS-CoV-2 antibody screening of 4840 staff members in a University Medical Center in France: a cross-sectional study. BMJ Open. 12(5). e047010–e047010. 1 indexed citations
3.
Castelain, Sandrine, Gilles Duverlie, O. Ganry, et al.. (2022). Certification ISO 9001 : 2015 de l’ensemble des activités de recherche d’un centre hospitalier universitaire. Therapies. 78(6). 721–732.
4.
Al‐Salameh, Abdallah, Jean‐Philippe Lanoix, Youssef Bennis, et al.. (2020). The association between body mass index class and coronavirus disease 2019 outcomes. International Journal of Obesity. 45(3). 700–705. 27 indexed citations
5.
Rossi, Cédric, Jérémie Jegu, Morgane Mounier, et al.. (2015). Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leukemia & lymphoma. 56(10). 2876–2882. 16 indexed citations
6.
Dakpé, Stéphanie, et al.. (2015). Faisabilité d’une stratégie de dépistage des lésions malignes de la cavité buccale chez les fumeurs. Revue de Stomatologie de Chirurgie Maxillo-faciale et de Chirurgie Orale. 116(2). 65–71. 1 indexed citations
7.
Schmit, J.L., et al.. (2015). Factors associated with time to mandatory tuberculosis notification in the Somme department, France. Revue d Épidémiologie et de Santé Publique. 63(5). 299–303. 3 indexed citations
8.
Jegu, Jérémie, Aurélien Belot, Christian Borel, et al.. (2015). Effect of previous history of cancer on survival of patients with a second cancer of the head and neck. Oral Oncology. 51(5). 457–463. 9 indexed citations
9.
Molinié, Florence, Christophe Leux, Patricia Delafosse, et al.. (2013). Waiting time disparities in breast cancer diagnosis and treatment: A population-based study in France. The Breast. 22(5). 810–816. 33 indexed citations
10.
Lanoix, Jean‐Philippe, Y. El Samad, Christine Robin, et al.. (2012). Assessing Urine Human Papillomavirus Polymerase Chain Reaction Testing As a Tool for Screening Anal HPV Infection in HIV-Positive MSM. AIDS Patient Care and STDs. 26(4). 208–213. 1 indexed citations
11.
Page, C., G. Mortuaire, F. Mouawad, et al.. (2012). Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience. European Archives of Oto-Rhino-Laryngology. 270(6). 1927–1932. 20 indexed citations
12.
Phelip, Jean–Marc, Florence Molinié, Patricia Delafosse, et al.. (2010). A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Gastroentérologie Clinique et Biologique. 34(2). 144–149. 12 indexed citations
13.
14.
Colonna, Marc, Arlette Danzon, Patricia Delafosse, et al.. (2007). Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012. European Journal of Cancer. 44(1). 115–122. 57 indexed citations
15.
Ganry, O., et al.. (2006). Ocular Complications of Atopic Dermatitis in Children. Acta Dermato Venereologica. 86(6). 515–517. 27 indexed citations
16.
Lescure, François-Xavier, M. Biendo, Guillaume Loup, et al.. (2006). Community-Acquired Infection With Healthcare-Associated Methicillin-Resistant Staphylococcus aureus: The Role of Home Nursing Care. Infection Control and Hospital Epidemiology. 27(11). 1213–1218. 34 indexed citations
17.
Ganry, O., et al.. (2004). Bone Mass Density and Risk of Breast Cancer and Survival in Older Women. European Journal of Epidemiology. 19(8). 785–792. 33 indexed citations
18.
Ganry, O., et al.. (2003). Evaluation of an algorithm to identify incident breast cancer cases using DRGs data. European Journal of Cancer Prevention. 12(4). 295–299. 18 indexed citations
19.
Ganry, O., et al.. (1999). Is there a reduced risk of breast cancer among women with hip fractures?. European Journal of Epidemiology. 15(4). 313–315. 17 indexed citations
20.
Boudailliez, B, et al.. (1998). Structure et fonctionnement d'une unité de médecine de l'adolescent; Fédération entre un service de pédiatrie et un service de psychopathologie. 45(5). 311–320. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026